# Nutrigenetics in Disease Prevention: Mechanistic Pathways and Risk Biomarkers

**Authors:** Ruth Birk

PMC · DOI: 10.3390/nu17132165 · Nutrients · 2025-06-29

## Full-text entities

- **Diseases:** hypertension (MESH:D006973), Skeletal Muscle Atrophy (MESH:D009133), injury to (MESH:D014947), Metabolic Syndrome (MESH:D024821), hyperglycemia (MESH:D006943), Asthma (MESH:D001249), NAFLD (MESH:D065626), cancer (MESH:D009369), Diabetic (MESH:D003920), overweight (MESH:D050177), Obesity (MESH:D009765), Chondrosarcoma (MESH:D002813), NSCLC (MESH:D002289)
- **Chemicals:** tocotrienols (MESH:D024508), 25(OH)D (-), Vitamin D (MESH:D014807), Dexamethasone (MESH:D003907), Delta-Tocotrienol (MESH:C082097), vitamin E (MESH:D014810), Gamma-Tocotrienol (MESH:C013649), Genistein (MESH:D019833), annatto (MESH:C054041), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs9939609, rs1544410

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12252080/full.md

---
Source: https://tomesphere.com/paper/PMC12252080